European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > A serious consideration about the wise use of the new, highly efficient, very expensive, treatment for cystic fibrosis (Trikafta©/Kaftrio©)

A serious consideration about the wise use of the new, highly efficient, very expensive, treatment for cystic fibrosis (Trikafta©/Kaftrio©)

Resource Type

CF Research News

Authors

Donatello Salvatore, Angela Pepe, Vincenzo Carnovale, Fabio Majo, Rita Padoan, Serena Quattrucci, Marco Salvatore, Domenica Taruscio, Annalisa Amato, Gianluca Ferrari, Giuseppe Campagna

References

J Cyst Fibros. 2021 Sep 25;S1569-1993(21)01416-8. doi: 10.1016/j.jcf.2021.09.011.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Psychosocial [3]

Keywords

CFTR modulator [4]
CFTR-related disorders [5]

Date

Saturday, September 25, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/serious-consideration-about-wise-use-new-highly-efficient-very

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00295_FINAL_Salvatore_250422.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34583889/ [3] https://www.ecfs.eu/research-article-themes/psychosocial [4] https://www.ecfs.eu/research-article-keywords/cftr-modulator [5] https://www.ecfs.eu/research-article-keywords/cftr-related-disorders-0 [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines